分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

FUT8 reprograms glycolytic metabolism to promote PKM2 lactylation and drive clear cell renal cell carcinoma progression

Guo Zikai, Jiang Hongxiao, Wang Xu, Xuan Ke, Zhong Huidong, Liu Chengxi, Zhang Mengkai, Li Zhichao, Huang Weiren, Sun Yangyang

Journal:Cell Death Discovery

IF:7

DOI:10.1038/s41420-026-03013-1

PMID:41857011

Published:2026-03-19

research field:肿瘤学分子生物学细胞信号传导癌症生物学代谢学

Abstract

Clear cell renal cell carcinoma (ccRCC) is characterized by the loss of the von Hippel–Lindau (VHL) gene, leading to constitutive activation of hypoxia-inducible transcription factors (HIFs) and metabolic reprogramming toward aerobic glycolysis. Although core fucosylation catalysed by fucosyltransferase 8 (FUT8) is known to regulate receptor signaling and tumor malignancy, its role in metabolic regulation of ccRCC remains poorly defined. Here, we demonstrate that FUT8 knockdown significantly suppresses ccRCC proliferation and migration both in vitro and in vivo. Mechanistically, FUT8 enhances HIF-1α–driven glycolysis, increasing lactate production and promoting pan-lysine lactylation (pan-Kla). Specifically, FUT8 promotes pyruvate kinase M2 (PKM2) K115 lactylation, which boosts its enzymatic activity while reducing nuclear localization, thereby driving epithelial–mesenchymal transition and malignant progression. Collectively, our findings reveal the FUT8–HIF-1α–lactate–PKM2 axis as a key mechanism that links core fucosylation to metabolic reprogramming and malignant progression in ccRCC and highlights FUT8 as a promising therapeutic target.

本文使用的Yeasen产品

购物车
客服
转染试用